Source:http://linkedlifedata.com/resource/pubmed/id/16414357
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-1-17
|
pubmed:abstractText |
Phospholipase A2 proteins are major regulators of the arachidonic acid cascade and are involved in various cellular responses. Previously, we reported that group IB PLA2 proteins stimulate MMP-2 activation and subsequent cell migration. Here, we describe a novel mechanism whereby sPLA2-induced proMMP-2 activation is regulated by intracellular cAMP in HT1080 cells, although sPLA2 itself had no effect on the regulation of cAMP levels. Exogenous dibutyryl cAMP (a cAMP analogue) strongly inhibited proMMP-2 activation, and cAMP elevating agents, namely, cholera toxin (a Gs activator) and forskolin (an adenylyl cyclase activator), abrogated basal and sPLA2-induced proMMP-2 activation. We also found that the down-regulation of TIMP-2 expression and extracellular signal-regulated kinase (ERK)1/2 activation by sPLA2 were blocked by increasing the intracellular cAMP level. Taken together, our data indicate that sPLA2-induced proMMP-2 activation is influenced by intracellular cAMP levels via the modulations of TIMP-2 expression and ERK1/2 activation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Group II Phospholipases A2,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipases A,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipases A2,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0006-291X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
24
|
pubmed:volume |
340
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1278-83
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16414357-Cell Line,
pubmed-meshheading:16414357-Cyclic AMP,
pubmed-meshheading:16414357-Enzyme Activation,
pubmed-meshheading:16414357-Fibrosarcoma,
pubmed-meshheading:16414357-Group II Phospholipases A2,
pubmed-meshheading:16414357-Humans,
pubmed-meshheading:16414357-MAP Kinase Signaling System,
pubmed-meshheading:16414357-Matrix Metalloproteinase 2,
pubmed-meshheading:16414357-Phospholipases A,
pubmed-meshheading:16414357-Phospholipases A2,
pubmed-meshheading:16414357-Tissue Inhibitor of Metalloproteinase-2,
pubmed-meshheading:16414357-Tissue Inhibitor of Metalloproteinases
|
pubmed:year |
2006
|
pubmed:articleTitle |
cAMP elevating agents suppress secretory phospholipase A(2)-induced matrix metalloproteinase-2 activation.
|
pubmed:affiliation |
Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu 705-035, South Korea; Aging-Associated Vascular Disease Research Center, Daegu 705-035, South Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|